NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 220)
Posted On: 02/14/2018 6:34:23 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Co-Marketing, Distribution Agreement with ISS, Inc.
Pressure BioSciences (OTCQB: PBIO) this morning said it has entered a two-year, global co-marketing and distribution agreement with ISS, Inc. The companies intend to combine the ISS high pressure optical cell with Pressure BioSciences’ automated high pressure instrument resulting in an exceptional analytical system with the potential to substantially improve biopharmaceutical drug discovery and development. High pressure optical spectroscopy is gaining popularity among scientists worldwide for its unique and effective way to look at molecular interactions. The new ISS/PBI instrument system is set to be unveiled at the annual Biophysical Society Meeting (“BPS”) which begins on February 17th in San Francisco, CA. “Interfacing the PBI HUB 440/880 pressure generators with the ISS high pressure optical cell system will allow scientists to visualize and measure pressure effects on molecular interactions and protein conformation as the reactions are taking place in the optical cell – in real time. This novel capability should help scientists better understand how proteins function and interact with other biomolecules, which is critically important in the development of better, more effective diagnostics and pharmaceuticals,” Pressure BioSciences VP of R&D, Dr. Alexander Lazarev stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) this morning said it has entered a two-year, global co-marketing and distribution agreement with ISS, Inc. The companies intend to combine the ISS high pressure optical cell with Pressure BioSciences’ automated high pressure instrument resulting in an exceptional analytical system with the potential to substantially improve biopharmaceutical drug discovery and development. High pressure optical spectroscopy is gaining popularity among scientists worldwide for its unique and effective way to look at molecular interactions. The new ISS/PBI instrument system is set to be unveiled at the annual Biophysical Society Meeting (“BPS”) which begins on February 17th in San Francisco, CA. “Interfacing the PBI HUB 440/880 pressure generators with the ISS high pressure optical cell system will allow scientists to visualize and measure pressure effects on molecular interactions and protein conformation as the reactions are taking place in the optical cell – in real time. This novel capability should help scientists better understand how proteins function and interact with other biomolecules, which is critically important in the development of better, more effective diagnostics and pharmaceuticals,” Pressure BioSciences VP of R&D, Dr. Alexander Lazarev stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼